Recent work in the Seyedsayamdost group in collaboration with the Sorensen group has enabled the biosynthesis of modified vancomycins with improved antibacterial activities.

Chemists in the lab of assistant professor Todd Hyster have found a way to make a naturally occurring enzyme take on a new, artificial role, which has significant implications for modern chemistry, including pharmaceutical production.